{"id":334,"date":"2025-09-24T16:08:00","date_gmt":"2025-09-24T10:38:00","guid":{"rendered":"https:\/\/www.najao.com\/learn\/?p=334"},"modified":"2026-01-26T04:36:27","modified_gmt":"2026-01-25T23:06:27","slug":"network-pharmacology","status":"publish","type":"post","link":"https:\/\/www.najao.com\/learn\/network-pharmacology\/","title":{"rendered":"Network Pharmacology: A Systems-Level Lens on Drugs and Disease"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Network Pharmacology is an integrated approach that helps us to view biological systems as a complex, interwoven network<strong><sup>1<\/sup><\/strong>. This is very different from conventional pharmacology, which focuses on the single-target approach, and aims to find one drug that acts on one specific target to treat one disease.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Currently, diseases are understood to arise from disruptions within complex, interconnected networks of multiple genes or proteins, which leads to systemic imbalances. Similarly, drugs often affect several molecules across different pathways rather than acting on only one target<strong><sup>2<\/sup><\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This concept has led to a paradigm shift due to advancements in high-throughput data obtained from diverse omics technologies such as genomics, proteomics, or metabolomics, and the rise of systems biology. Researchers have found that understanding biological function and dysfunction requires us to understand molecular interactions as a whole rather than focusing solely on individual components<strong><sup>3<\/sup><\/strong>. On this premise, network pharmacology emerged as a logical response to this complexity, bringing together tools from bioinformatics, systems biology, and pharmacology.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why network pharmacology matters<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Network pharmacology helps provide therapeutic interventions for some of the biggest medical challenges by considering the real-world complexity of human biology. For example:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Complex diseases like <a href=\"https:\/\/www.najao.com\/learn\/cancer-carcinogenesis\/\" target=\"_blank\" rel=\"noreferrer noopener\">cancer<\/a> or <a href=\"https:\/\/www.najao.com\/learn\/alzheimers-disease\/\" target=\"_blank\" rel=\"noreferrer noopener\">Alzheimer&#8217;s<\/a> are found to be caused by failures in multiple metabolic pathways at different phases of disease progression. Thus, therapeutic strategies should follow a multi-targeted approach<strong><sup>4<\/sup><\/strong>.<\/li>\n\n\n\n<li>Polypharmacology is about designing drugs that affect multiple targets or metabolic pathways<strong><sup>2<\/sup><\/strong>. This can be better understood and employed with the knowledge of network pharmacology.<\/li>\n\n\n\n<li>Drug combinations can be strategically formulated to achieve synergistic therapeutic effects<strong><sup>5<\/sup><\/strong>.<\/li>\n\n\n\n<li><a href=\"https:\/\/www.nia.nih.gov\/research\/milestones\/translational-clinical-research\/pharmacological\/milestone-7-b\" target=\"_blank\" rel=\"noreferrer noopener\">Drug repurposing<\/a> is the process of identifying new uses for existing drugs<strong><sup>6<\/sup><\/strong>. This will help in identifying unexpected connections between old drugs and new uses.<\/li>\n\n\n\n<li>Most importantly, it will boost <a href=\"https:\/\/www.najao.com\/learn\/precision-medicine\/\" target=\"_blank\" rel=\"noreferrer noopener\">personalized treatment<\/a>, which is tailored to the unique molecular network of each patient<strong><sup>7<\/sup><\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Understanding biological networks<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Networks are maps of interacting entities such as genes, proteins, metabolites, and drugs. They are commonly made up of nodes, for example, proteins or drugs, connected by edges, which are interactions like binding or regulation. For example, some networks represent protein-protein interactions, metabolic pathways, or gene regulation<strong><sup>8-10<\/sup><\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Hubs, which are nodes with many connections, are crucial for understanding key features in disease diagnosis and prognosis<strong><sup>11<\/sup><\/strong>. They are often vital for maintaining the stability of modules, which are clusters of related nodes that perform specific biological functions. The core philosophy of network pharmacology is the understanding of how a disease causes imbalances in these networks and how drugs can restore that balance.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">The network pharmacology workflow<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Network Pharmacology operates through a structured but dynamic workflow that moves from data collection to actionable insight.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>1. Data collection and integration<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It includes the collection of high-quality data from diverse sources such as<strong><sup>12<\/sup><\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Annotation of genes and proteins from genome databases.<\/li>\n\n\n\n<li>Drug-receptor information from drug and chemical databases.<\/li>\n\n\n\n<li>Molecular interaction data from curated network databases.<\/li>\n\n\n\n<li>Clinical outcomes and patient-specific <a href=\"https:\/\/www.najao.com\/learn\/multi-omics\/\" target=\"_blank\" rel=\"noreferrer noopener\">omics data<\/a>.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>2. Network construction<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">After data collection, relevant networks are developed. For example: Disease-specific networks connect respective genes and proteins<strong><sup>13<\/sup><\/strong>. Drug-target networks help in understanding known or predicted interactions<strong><sup>14<\/sup><\/strong>. Integrated networks help predict drugs onto disease networks, which highlights potential intervention points<strong><sup>15<\/sup><\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>3. Network analysis<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This stage utilizes computational methods to analyze these networks and derive meaningful insights<strong><sup>16<\/sup><\/strong>. This involves:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Identifying hubs and bottlenecks<strong><sup>17<\/sup><\/strong>.<\/li>\n\n\n\n<li>Detecting disease modules that serve as therapeutic targets<strong><sup>18<\/sup><\/strong>.<\/li>\n\n\n\n<li>Using algorithms to simulate how disease or drug-related changes affect the system<strong><sup>19<\/sup><\/strong>.<\/li>\n\n\n\n<li>Performing enrichment analyses to connect network components to known biological pathways<strong><sup>20<\/sup><\/strong>.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>4. Prediction of drug-target interactions<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">After successful network analysis, novel interactions can be predicted<strong><sup>21<\/sup><\/strong>. This involves searching for drugs that are structurally or chemically similar to known drugs, molecular docking to target proteins, and then employing network algorithms that identify optimal points for intervention.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>5. Validation<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">After the successful prediction of drug-target interactions, every hypothesis generated computationally must be tested. For example: <em>In vitro<\/em> experiments are to be performed to confirm molecular interactions or cellular responses<strong><sup>22<\/sup><\/strong>. This should be followed by <em>in vivo<\/em> models to test safety and efficacy in living organisms<strong><sup>23<\/sup><\/strong>. Lastly, clinical trials assess the real-world performance of candidate drugs<strong><sup>24<\/sup><\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Real-world applications<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Network pharmacology has broad applicability across many areas of medicine.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Drug discovery and repurposing<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Network analysis has led to the discovery of new targets for existing drugs, which helps to reduce costs and timelines<strong><sup>16<\/sup><\/strong>. It also enables the design of multi-target drugs, engineered to influence several points within a disease network where single-agent therapies often fail<strong><sup>25<\/sup><\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Decoding disease mechanisms<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Mapping disease networks helps researchers identify disruptions in metabolic pathways, understand how diseases vary between patients, and pinpoint where shared mechanisms exist across multiple conditions<strong><sup>26<\/sup><\/strong>. This provides a clearer picture of disease biology and helps to adapt treatments to different stages.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Biomarker discovery<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Network-based biomarker discovery differs from conventional searching methodologies that involve single molecules<strong><sup>27<\/sup><\/strong>. Instead, entire modules or subnetworks can act as disease signatures. This offers richer diagnostic and prognostic information or helps to predict therapeutic responses with greater accuracy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Toward personalized medicine<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The ultimate goal of 21<sup>st<\/sup>-century medicine is to develop personalized network models from a patient\u2019s own omics data<strong><sup>28<\/sup><\/strong>. These models can help doctors decide which drugs will work best, anticipate potential side effects, and predict how a patient&#8217;s disease is likely to progress.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bridging traditional and modern medicine<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Network pharmacology has helped provide a scientific foundation for herbal medicine, including Traditional Chinese Medicine (TCM)<strong><sup>29<\/sup><\/strong>. The therapeutic effects of herbal compounds can be explained and enhanced by researchers who map their interactions onto biological networks.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Navigating challenges<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Despite its promise, the field of network pharmacology faces several serious hurdles:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The reliability of a network analysis depends on its input data<strong><sup>30<\/sup><\/strong>. Missing or inaccurate information about interactions can lead to distorted or misleading results.<\/li>\n\n\n\n<li>Most of our current network models are static, so they don&#8217;t change over time, but real biological systems are always changing<strong><sup>31<\/sup><\/strong>. This makes it hard to understand how diseases and drugs work, since their effects depend on time and specific situations.<\/li>\n\n\n\n<li>Integrating massive, heterogeneous datasets and running network algorithms requires specialized tools, significant computing power, and expert knowledge<strong><sup>1<\/sup><\/strong>.<\/li>\n\n\n\n<li>Translating predictions from <em>in silico<\/em> computational models into clinical use is a slow and resource-intensive process<strong><sup>32<\/sup><\/strong>.<\/li>\n\n\n\n<li>Understanding dense networks is challenging and requires a mix of strong computational skills to handle the data and deep biological intuition to make sense of the results<strong><sup>1<\/sup><\/strong>.<\/li>\n\n\n\n<li>When a drug exhibits polypharmacology by binding to multiple targets, it is very difficult to differentiate between its intended therapeutic effects and harmful off-target interactions<strong><sup>2<\/sup><\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Future directions<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">With the latest technological developments, network pharmacology is poised to shape the future of medicine:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.najao.com\/learn\/single-cell-technology\/\" target=\"_blank\" rel=\"noreferrer noopener\">Single-cell<\/a> network analysis involves studying the complex relationships and interactions within individual cells<strong><sup>33<\/sup><\/strong>. This offers unprecedented resolution on disease heterogeneity and cellular-level dynamics.<\/li>\n\n\n\n<li>New models aim to capture the temporal shifts and feedback loops in biological systems, which is a significant improvement over the static models used earlier<strong><sup>31<\/sup><\/strong>.<\/li>\n\n\n\n<li>Integration with structural biology helps with the precise prediction of molecular interactions at the atomic level within larger networks<strong><sup>34<\/sup><\/strong>.<\/li>\n\n\n\n<li><a href=\"https:\/\/www.najao.com\/learn\/artificial-intelligence-applications-in-healthcare\/\" target=\"_blank\" rel=\"noreferrer noopener\">Artificial intelligence<\/a> (AI) and deep learning help locate meaningful patterns in huge datasets and model complex interactions. This is further supported by advanced models, such as Explainable AI (XAI), that help clinicians interpret results in a better way<strong><sup>35<\/sup><\/strong>.<\/li>\n\n\n\n<li>By guiding real-time treatment decisions and drug development, computational models are expected to close the gap between research and patient care<strong><sup>36<\/sup><\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Network pharmacology is a paradigm shift in how we understand disease and therapy. It embraces a systems biology approach by exploring the dynamic and interconnected web of interactions. This helps to form a more accurate, efficient, and holistic understanding of health and disease, which in turn allows us to tackle complex diseases with smarter strategies. It also opens new doors for drug discovery, repurposing, and better personalized treatment. With the latest advancements in big data, AI, and diverse interdisciplinary collaboration, network pharmacology is set to revolutionize healthcare.<\/p>\n\n\n\n<!--nextpage-->\n\n\n\n<h2 class=\"wp-block-heading\">FAQs<\/h2>\n\n\n\n<h4 class=\"wp-block-heading\">1. Is network pharmacology a type of bioinformatics?<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Network pharmacology is an interdisciplinary field that uses bioinformatics, but it&#8217;s not a subfield of it. Bioinformatics provides the computational tools and methods for analyzing biological data and building networks. Network pharmacology uses these tools, along with principles from pharmacology and systems biology, and applies that network-based knowledge to drug discovery and therapeutic strategies.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">2. How does network pharmacology help reduce drug side effects?<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Network pharmacology allows researchers to map a drug&#8217;s interactions across a whole network. This enables them to identify potential unintended targets of the drug that might cause adverse effects. Researchers can then either modify the drug or choose a different one with a more favorable network profile.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">3. How can network pharmacology be used to study drug resistance?<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Network pharmacology can be used to model the redundancy and alternative pathways within a biological system. This reveals how disease networks adapt to evade drugs, which helps to identify potential multi-target treatments or combinations to prevent or overcome resistance.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Reference<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">1. Hopkins, A. L. (2008). Network pharmacology: the next paradigm in drug discovery.&nbsp;<em>Nature chemical biology<\/em>,&nbsp;<em>4<\/em>(11), 682-690.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">2. Reddy, A. S., &amp; Zhang, S. (2013). Polypharmacology: drug discovery for the future.&nbsp;<em>Expert review of clinical pharmacology<\/em>,&nbsp;<em>6<\/em>(1), 41-47.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">3. Grennan, K. S., Chen, C., Gershon, E. S., <em>et al<\/em>. (2014). Molecular network analysis enhances understanding of the biology of mental disorders.&nbsp;<em>Bioessays<\/em>,&nbsp;<em>36<\/em>(6), 606-616.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">4. Hossain, M. S., &amp; Hussain, M. H. (2025). Multi\u2010Target Drug Design in Alzheimer&#8217;s Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations.&nbsp;<em>Pharmacology Research &amp; Perspectives<\/em>,&nbsp;<em>13<\/em>(4), e70131.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">5. Leh\u00e1r, J., Krueger, A. S., Avery, W., <em>et al<\/em>. (2009). Synergistic drug combinations tend to improve therapeutically relevant selectivity.&nbsp;<em>Nature biotechnology<\/em>,&nbsp;<em>27<\/em>(7), 659-666.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">6. Parvathaneni, V., Kulkarni, N. S., Muth, A., <em>et al<\/em>. (2019). Drug repurposing: a promising tool to accelerate the drug discovery process.&nbsp;<em>Drug discovery today<\/em>,&nbsp;<em>24<\/em>(10), 2076-2085.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">7. Li, L., Yang, L., Yang, L., <em>et al<\/em>. (2023). Network pharmacology: a bright guiding light on the way to explore the personalized precise medication of traditional Chinese medicine.&nbsp;<em>Chinese medicine<\/em>,&nbsp;<em>18<\/em>(1), 146.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">8. Koh, G. C., Porras, P., Aranda, B., <em>et al<\/em>. (2012). Analyzing protein\u2013protein interaction networks.&nbsp;<em>Journal of proteome research<\/em>,&nbsp;<em>11<\/em>(4), 2014-2031.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">9. Stitt, M., Sulpice, R., &amp; Keurentjes, J. (2010). Metabolic Networks: How to Identify Key Components in the Regulation of Metabolism and Growth.&nbsp;<em>Plant Physiology<\/em>,&nbsp;<em>152<\/em>(2), 428.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">10. Levine, M., &amp; Davidson, E. H. (2005). Gene regulatory networks for development.&nbsp;<em>Proceedings of the National Academy of Sciences<\/em>,&nbsp;<em>102<\/em>(14), 4936-4942.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">11. Lei, X., Zhang, M., Guan, B., <em>et al<\/em>. (2021). Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.&nbsp;<em>Human genomics<\/em>,&nbsp;<em>15<\/em>(1), 39.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">12. Nogales, C., Mamdouh, Z. M., List, M., <em>et al<\/em>. (2022). Network pharmacology: curing causal mechanisms instead of treating symptoms.&nbsp;<em>Trends in pharmacological sciences<\/em>,&nbsp;<em>43<\/em>(2), 136-150.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">13. Liu, Q., Chen, Z., Wang, B., <em>et al<\/em>. (2025). Leveraging Network Target Theory for Efficient Prediction of Drug\u2010Disease Interactions: A Transfer Learning Approach.&nbsp;<em>Advanced Science<\/em>,&nbsp;<em>12<\/em>(11), 2409130.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">14. Chen, S., Jiang, H., Cao, Y., <em>et al<\/em>. (2016). Drug target identification using network analysis: taking active components in Sini decoction as an example.&nbsp;<em>Scientific reports<\/em>,&nbsp;<em>6<\/em>(1), 24245.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">15. Huang, W., Liu, C., Xie, L., <em>et al<\/em>. (2019). Integrated network pharmacology and targeted metabolomics to reveal the mechanism of nephrotoxicity of triptolide.&nbsp;<em>Toxicology research<\/em>,&nbsp;<em>8<\/em>(6), 850-861.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">16. Chandran, U., Mehendale, N., Patil, S., <em>et al<\/em>. (2016). Network pharmacology.&nbsp;<em>Innovative approaches in drug discovery<\/em>, 127.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">17. Lin, C. Y., Chin, C. H., Wu, H. H., <em>et al<\/em>. (2008). Hubba: hub objects analyzer\u2014a framework of interactome hubs identification for network biology.&nbsp;<em>Nucleic acids research<\/em>,&nbsp;<em>36<\/em>(suppl_2), W438-W443.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">18. Yan, C., Zhang, Z., Bao, S., <em>et al<\/em>. (2020). Computational methods and applications for identifying disease-associated lncRNAs as potential biomarkers and therapeutic targets.&nbsp;<em>Molecular Therapy Nucleic Acids<\/em>,&nbsp;<em>21<\/em>, 156-171.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">19. Serrano, D. R., Luciano, F. C., Anaya, B. J., <em>et al<\/em>. (2024). Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine.&nbsp;<em>Pharmaceutics<\/em>,&nbsp;<em>16<\/em>(10), 1328.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">20. Alexeyenko, A., Lee, W., Pernemalm, M., <em>et al<\/em>. (2012). Network enrichment analysis: extension of gene-set enrichment analysis to gene networks.&nbsp;<em>BMC bioinformatics<\/em>,&nbsp;<em>13<\/em>(1), 226.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">21. Wu, Z., Li, W., Liu, G., <em>et al<\/em>. (2018). Network-based methods for prediction of drug-target interactions.&nbsp;<em>Frontiers in pharmacology<\/em>,&nbsp;<em>9<\/em>, 1134.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">22. Li, H., Zhao, L., Zhang, B., <em>et al<\/em>. (2014). A network pharmacology approach to determine active compounds and action mechanisms of ge\u2010gen\u2010qin\u2010lian decoction for treatment of type 2 diabetes.&nbsp;<em>Evidence<\/em><em>\u2010based Complementary and Alternative Medicine<\/em>,&nbsp;<em>2014<\/em>(1), 495840.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">23. Morgan, S. J., Elangbam, C. S., Berens, S., <em>et al<\/em>. (2013). Use of animal models of human disease for nonclinical safety assessment of novel pharmaceuticals.&nbsp;<em>Toxicologic pathology<\/em>,&nbsp;<em>41<\/em>(3), 508-518.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">24. Brody, T. (2016).&nbsp;<em>Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines<\/em>. Academic press.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">25. Tang, J., &amp; Aittokallio, T. (2014). Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles.&nbsp;<em>Current Pharmaceutical Design<\/em>,&nbsp;<em>20<\/em>(1), 20.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">26. Chen, H., Zhu, Z., Zhu, Y., <em>et al<\/em>. (2015). Pathway mapping and development of disease\u2010specific biomarkers: protein\u2010based network biomarkers.&nbsp;<em>Journal of Cellular and Molecular medicine<\/em>,&nbsp;<em>19<\/em>(2), 297-314.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">27. Zhang, W., Chen, Y., Jiang, H., <em>et al<\/em>. (2020). Integrated strategy for accurately screening biomarkers based on metabolomics coupled with network pharmacology.&nbsp;<em>Talanta<\/em>,&nbsp;<em>211<\/em>, 120710.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">28. Kidd, B. A., Readhead, B. P., Eden, C., <em>et al<\/em>. (2015). Integrative network modeling approaches to personalized cancer medicine.&nbsp;<em>Personalized medicine<\/em>,&nbsp;<em>12<\/em>(3), 245-257.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">29. Li, L., Yang, L., Yang, L., <em>et al<\/em>. (2023). Network pharmacology: a bright guiding light on the way to explore the personalized precise medication of traditional Chinese medicine.&nbsp;<em>Chinese medicine<\/em>,&nbsp;<em>18<\/em>(1), 146.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">30. Gokulakrishnan, D., &amp; Venkataraman, S. (2024). Ensuring data integrity: Best practices and strategies in pharmaceutical industry, <em>Intelligent Pharmacy, 3<\/em>(4), 296-303.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">31. Bloomingdale, P., Nguyen, V. A., Niu, J., <em>et al<\/em>. (2018). Boolean network modeling in systems pharmacology.&nbsp;<em>Journal of pharmacokinetics and pharmacodynamics<\/em>,&nbsp;<em>45<\/em>(1), 159-180.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">32. Patel, A., Parab, S., Gupta, S., <em>et al<\/em>. (2025). Pharmaceutical Inhalation Compounds Development by Using In Silico Modeling Tools. In&nbsp;<em>Applications of Computational Tools in Drug Design and Development<\/em>&nbsp;(pp. 279-309). Singapore: Springer Nature Singapore.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">33. Khozyainova, A. A., Valyaeva, A. A., Arbatsky, M. S., <em>et al<\/em>. (2023). Complex analysis of single-cell RNA sequencing data.&nbsp;<em>Biochemistry (Moscow)<\/em>,&nbsp;<em>88<\/em>(2), 231-252.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">34. Duran-Frigola, M., Mosca, R., &amp; Aloy, P. (2013). Structural systems pharmacology: the role of 3D structures in next-generation drug development.&nbsp;<em>Chemistry &amp; biology<\/em>,&nbsp;<em>20<\/em>(5), 674-684.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">35. Proietti, M., Ragno, A., Rosa, B. L., <em>et al<\/em>. (2024). Explainable AI in drug discovery: self-interpretable graph neural network for molecular property prediction using concept whitening.&nbsp;<em>Machine Learning<\/em>,&nbsp;<em>113<\/em>(4), 2013-2044.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">36. Madabushi, R., Seo, P., Zhao, L., <em>et al<\/em>. (2022). Role of model-informed drug development approaches in the lifecycle of drug development and regulatory decision-making.&nbsp;<em>Pharmaceutical Research<\/em>,&nbsp;<em>39<\/em>(8), 1669.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Network pharmacology is an integrated approach that combines insights from bioinformatics, systems biology, and pharmacology to help us view biological systems as a complex, interwoven network. This, in turn, allows for a more accurate, efficient, and holistic understanding of health and disease.<\/p>\n","protected":false},"author":3,"featured_media":335,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13,17,16,14,8,18],"tags":[],"coauthors":[10,9],"class_list":["post-334","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biochemistry","category-biomedical-engineering","category-biotechnology","category-genetics","category-healthcare","category-molecular-biology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Network Pharmacology: Decoding Drug-Disease Interactions<\/title>\n<meta name=\"description\" content=\"Network Pharmacology is an integrated approach that helps us to view biological systems as a complex, interwoven network.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.najao.com\/learn\/network-pharmacology\/\" \/>\n<link rel=\"next\" href=\"https:\/\/www.najao.com\/learn\/network-pharmacology\/2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Network Pharmacology: Decoding Drug-Disease Interactions\" \/>\n<meta property=\"og:description\" content=\"Network Pharmacology is an integrated approach that helps us to view biological systems as a complex, interwoven network.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.najao.com\/learn\/network-pharmacology\/\" \/>\n<meta property=\"og:site_name\" content=\"Najao Inovix\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/najaoinovix\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-24T10:38:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-25T23:06:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/12\/Network-Pharmacology.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"864\" \/>\n\t<meta property=\"og:image:height\" content=\"1184\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sujay Ghosh, Anwesha Acharyya\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@najaoinovix\" \/>\n<meta name=\"twitter:site\" content=\"@najaoinovix\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sujay Ghosh, Anwesha Acharyya\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/network-pharmacology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/network-pharmacology\\\/\"},\"author\":{\"name\":\"Sujay Ghosh\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#\\\/schema\\\/person\\\/dce56c4224dfcacff6edf2e58f0f68d2\"},\"headline\":\"Network Pharmacology: A Systems-Level Lens on Drugs and Disease\",\"datePublished\":\"2025-09-24T10:38:00+00:00\",\"dateModified\":\"2026-01-25T23:06:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/network-pharmacology\\\/\"},\"wordCount\":2402,\"publisher\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/network-pharmacology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Network-Pharmacology.jpg\",\"articleSection\":[\"Biochemistry\",\"Biomedical Engineering\",\"Biotechnology\",\"Genetics\",\"Healthcare\",\"Molecular Biology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/network-pharmacology\\\/\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/network-pharmacology\\\/\",\"name\":\"Network Pharmacology: Decoding Drug-Disease Interactions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/network-pharmacology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/network-pharmacology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Network-Pharmacology.jpg\",\"datePublished\":\"2025-09-24T10:38:00+00:00\",\"dateModified\":\"2026-01-25T23:06:27+00:00\",\"description\":\"Network Pharmacology is an integrated approach that helps us to view biological systems as a complex, interwoven network.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.najao.com\\\/learn\\\/network-pharmacology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/network-pharmacology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Network-Pharmacology.jpg\",\"contentUrl\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Network-Pharmacology.jpg\",\"width\":864,\"height\":1184,\"caption\":\"Network Pharmacology\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#website\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/\",\"name\":\"Najao Inovix\",\"description\":\"Cooperation for Success\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#organization\",\"name\":\"Najao Inovix\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Najao-Favicon.png\",\"contentUrl\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Najao-Favicon.png\",\"width\":2490,\"height\":2490,\"caption\":\"Najao Inovix\"},\"image\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/najaoinovix\\\/\",\"https:\\\/\\\/x.com\\\/najaoinovix\",\"https:\\\/\\\/www.instagram.com\\\/najaoinovix\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/najao\\\/\",\"https:\\\/\\\/www.threads.com\\\/@najaoinovix\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#\\\/schema\\\/person\\\/dce56c4224dfcacff6edf2e58f0f68d2\",\"name\":\"Sujay Ghosh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75020d47c7623402695f739d0e19add7e387d7645c2f867ea8bdd24f4d8e6f92?s=96&d=mm&r=g0181851cb7cff8a9fa8e05f03e21ab7b\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75020d47c7623402695f739d0e19add7e387d7645c2f867ea8bdd24f4d8e6f92?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75020d47c7623402695f739d0e19add7e387d7645c2f867ea8bdd24f4d8e6f92?s=96&d=mm&r=g\",\"caption\":\"Sujay Ghosh\"},\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/author\\\/sujay\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Network Pharmacology: Decoding Drug-Disease Interactions","description":"Network Pharmacology is an integrated approach that helps us to view biological systems as a complex, interwoven network.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.najao.com\/learn\/network-pharmacology\/","next":"https:\/\/www.najao.com\/learn\/network-pharmacology\/2\/","og_locale":"en_US","og_type":"article","og_title":"Network Pharmacology: Decoding Drug-Disease Interactions","og_description":"Network Pharmacology is an integrated approach that helps us to view biological systems as a complex, interwoven network.","og_url":"https:\/\/www.najao.com\/learn\/network-pharmacology\/","og_site_name":"Najao Inovix","article_publisher":"https:\/\/www.facebook.com\/najaoinovix\/","article_published_time":"2025-09-24T10:38:00+00:00","article_modified_time":"2026-01-25T23:06:27+00:00","og_image":[{"width":864,"height":1184,"url":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/12\/Network-Pharmacology.jpg","type":"image\/jpeg"}],"author":"Sujay Ghosh, Anwesha Acharyya","twitter_card":"summary_large_image","twitter_creator":"@najaoinovix","twitter_site":"@najaoinovix","twitter_misc":{"Written by":"Sujay Ghosh, Anwesha Acharyya","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.najao.com\/learn\/network-pharmacology\/#article","isPartOf":{"@id":"https:\/\/www.najao.com\/learn\/network-pharmacology\/"},"author":{"name":"Sujay Ghosh","@id":"https:\/\/www.najao.com\/learn\/#\/schema\/person\/dce56c4224dfcacff6edf2e58f0f68d2"},"headline":"Network Pharmacology: A Systems-Level Lens on Drugs and Disease","datePublished":"2025-09-24T10:38:00+00:00","dateModified":"2026-01-25T23:06:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.najao.com\/learn\/network-pharmacology\/"},"wordCount":2402,"publisher":{"@id":"https:\/\/www.najao.com\/learn\/#organization"},"image":{"@id":"https:\/\/www.najao.com\/learn\/network-pharmacology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/12\/Network-Pharmacology.jpg","articleSection":["Biochemistry","Biomedical Engineering","Biotechnology","Genetics","Healthcare","Molecular Biology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.najao.com\/learn\/network-pharmacology\/","url":"https:\/\/www.najao.com\/learn\/network-pharmacology\/","name":"Network Pharmacology: Decoding Drug-Disease Interactions","isPartOf":{"@id":"https:\/\/www.najao.com\/learn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.najao.com\/learn\/network-pharmacology\/#primaryimage"},"image":{"@id":"https:\/\/www.najao.com\/learn\/network-pharmacology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/12\/Network-Pharmacology.jpg","datePublished":"2025-09-24T10:38:00+00:00","dateModified":"2026-01-25T23:06:27+00:00","description":"Network Pharmacology is an integrated approach that helps us to view biological systems as a complex, interwoven network.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.najao.com\/learn\/network-pharmacology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.najao.com\/learn\/network-pharmacology\/#primaryimage","url":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/12\/Network-Pharmacology.jpg","contentUrl":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/12\/Network-Pharmacology.jpg","width":864,"height":1184,"caption":"Network Pharmacology"},{"@type":"WebSite","@id":"https:\/\/www.najao.com\/learn\/#website","url":"https:\/\/www.najao.com\/learn\/","name":"Najao Inovix","description":"Cooperation for Success","publisher":{"@id":"https:\/\/www.najao.com\/learn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.najao.com\/learn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.najao.com\/learn\/#organization","name":"Najao Inovix","url":"https:\/\/www.najao.com\/learn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.najao.com\/learn\/#\/schema\/logo\/image\/","url":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/05\/Najao-Favicon.png","contentUrl":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/05\/Najao-Favicon.png","width":2490,"height":2490,"caption":"Najao Inovix"},"image":{"@id":"https:\/\/www.najao.com\/learn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/najaoinovix\/","https:\/\/x.com\/najaoinovix","https:\/\/www.instagram.com\/najaoinovix\/","https:\/\/www.linkedin.com\/company\/najao\/","https:\/\/www.threads.com\/@najaoinovix"]},{"@type":"Person","@id":"https:\/\/www.najao.com\/learn\/#\/schema\/person\/dce56c4224dfcacff6edf2e58f0f68d2","name":"Sujay Ghosh","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/75020d47c7623402695f739d0e19add7e387d7645c2f867ea8bdd24f4d8e6f92?s=96&d=mm&r=g0181851cb7cff8a9fa8e05f03e21ab7b","url":"https:\/\/secure.gravatar.com\/avatar\/75020d47c7623402695f739d0e19add7e387d7645c2f867ea8bdd24f4d8e6f92?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/75020d47c7623402695f739d0e19add7e387d7645c2f867ea8bdd24f4d8e6f92?s=96&d=mm&r=g","caption":"Sujay Ghosh"},"url":"https:\/\/www.najao.com\/learn\/author\/sujay\/"}]}},"_links":{"self":[{"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/posts\/334","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/comments?post=334"}],"version-history":[{"count":2,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/posts\/334\/revisions"}],"predecessor-version":[{"id":419,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/posts\/334\/revisions\/419"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/media\/335"}],"wp:attachment":[{"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/media?parent=334"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/categories?post=334"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/tags?post=334"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/coauthors?post=334"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}